Prescription Dermatology
Thiamidol / Isobutylamido Thiazolyl Resorcinol
Tyrosinase-inhibiting brightening topical for hyperpigmentation
시술 시간
외용매일
다운타임
なし
권장 횟수
8-12주で効果判定
이 치료에 대해
Thiamidol is a human tyrosinase-targeting brightening active used for melasma, solar lentigines, PIH and post-laser pigmentation prevention support.
It is generally easier to integrate into daily care than stronger depigmenting prescriptions, but severe melasma often requires combination therapy.
작용 기전
It inhibits human tyrosinase activity and reduces melanogenesis; photoprotection reduces new pigment stimulation.
적응증
색소·칙칙함일반 적응증(상세 설명 참고)
기대 효과
Pigment scores and photography are assessed after 8-12 weeks. It is useful as post-procedure maintenance care.
임상 근거
Arrowitz C, et al. (2019)
Effective tyrosinase inhibition by thiamidol in human pigmentation models. J Invest Dermatol
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
Melasma skin-of-color investigators (2025)
Thiamidol in melasma in patients of skin of color. Dermatol Ther
해당 연구에서 임상적 개선이 보고되었습니다(자세한 내용은 원문 논문 참조).
위험 및 부작용
Mild irritation, redness, dryness and contact dermatitis may occur. Follow product labeling and medical advice in pregnancy/lactation.